medigraphic.com
ISSN 1561-3062 (Electronic)

2012, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2012; 38 (4)

Maternal-perinatal outcome of patients with pre-eclampsia

García MR, Llera VA, Pacheco BAL, Delgado GMJ, González SA

Language: Spanish
References: 24
Page:
PDF size: 67.47 Kb.


ABSTRACT

Introduction: pre-eclampsia is the most common medical complication of pregnancy. In Cuba, an incidence of 5-10 % was found and it is one of the leading causes of maternal and perinatal morbidity.
Objective: to characterize the behavior of maternal-perinatal outcome in patients with pre-eclampsia.
Methods: an observational study of cases and controls was conducted from January 1st. January 2008 to 31 December 2009, at Eusebio Hernández OB/GYN Hospital in Havana. We considered as cases, 172 patients with previous diagnosis of pre-eclampsia and as controls, 7916 patients who did not have this diagnosis.
Results: most of the pregnant women were included in the age range 20-34 years. The most frequent risk factors observed in patients with pre-eclampsia was nulliparity (82.5 %) and extreme maternal age (26.7 %). Cesarean section was used more frequently in pre-eclamptic patients (59.3 %), also the likelihood of having preterm labor was 5.5 times more in these patients.
Conclusions: the likelihood of developing eclampsia was almost 21 times less in patients with pre-eclampsia, who used magnesium sulfate. The most common perinatal and maternal complications were severe pre-eclampsia, retroplacental hematoma, weighing bellow 1 500 g, and hyaline membrane disease in the newborn.


REFERENCES

  1. Bolte AC, Van Geijn HP. Fisiopatología de la Preeclampsia y papel de la Serotonina. European Journal of Obstetrics & Gynecology and Reproductive Biology (Ed. Española). 2001;1:322-32.

  2. Duley L. Seminaris in Perinatology. 2009;33(3):130-7.

  3. Cruz Laguna GM, Uribasterra Campos A, González Balmaseda A, Martín Cuayo A. Comportamiento del bajo peso al nacer. Hospital Docente Vladimir I. Lenin.1999-2003. Correo Científico Médico de Holguín. 2005;9(2).

  4. Finnerty FA. Toxemia del embarazo: diagnóstico clínico actual. Barcelona: Editorial Labor; 2001. p. 94-101.

  5. Castro Santoro R. Adolescente embarazada: aspectos orgánicos. Embarazos en adolescentes. Diagnóstico 1991. Santiago de Chile: SERNAM UNICEF; 1992.

  6. Suárez González JA, Gutiérrez Machado M. Predictores de la preeclampsia/eclampsia en un grupo de gestantes de alto riesgo. Rev Cubana Obstet Ginecol; 2011;37(2):154-61.

  7. Suárez González JA. Comportamiento materno y perinatal de un grupo de gestantes con preeclampsia grave. Rev Cubana Obstet Ginecol. 2009;35(3).

  8. Ñáñez Burbano H, Ruiz Parra AI. Hipertensión y Embarazo en: Texto de Obstetricia y Perinatología: Editorial Pharmacia Upjohn. 1999;33:485-523.

  9. Robyn A North, Lesley ME McCowan, Gustaaf A Dekker, Lucilla Poston. Predicción del riesgo de preeclampsia en nulíparas. BMJ. 2011;342:d1875.

  10. Quintana NP, Rey DF. Desarrollo y Definición. Revista de Posgrado de la VIa Cátedra de Medicina. 2003;133:20.

  11. Guarilia D. Epidemiología En: Guariglia D, editor. Hipertensión en el embarazo. Bogotá: Disinlimed; 2006. p. 25-34.

  12. Sánchez S, Ware-Jauregui S, Larrabure G, Bazul V, Ingar H, Zhang C, et al. Factores de riesgo de preeclampsia en mujeres peruanas. Ginecol Obstet. 2001;47:102-11.

  13. Garner PR, D'Alton ME, Dudley DK, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol. 1990 Aug;163(2):505-8.

  14. Report of the National High Blood Pressure Education. Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.

  15. Fragieh AY, Sibai. MB. Preeclampsia: Diagnóstico y Manejo. Tratamiento de las complicaciones clínicas del embarazo. Norbert Gleicher. Buenos Aires: Editorial Médica Panamericana; 2000.

  16. Leis Márquez MT, Rodríguez Bosch MR, García López MA. Clinical practice guidelines. Diagnosis and treatment of preeclampsia-eclampsia. Colegio Mexicano de Especialistas en Ginecología y Obstetricia. Ginecol Obstet Mex. 2010;78(6):S461-525.

  17. Orizondo Ansola R, Cairo González V. Eclampsia en Santa Clara. Rev Cubana Obstet Ginecol. 2009;35(3).

  18. Villanueva A, Alanis P. Factores relacionados con el pronóstico del síndrome HELLP en mujeres con preeclampsia grave. Ginecol Obstet Mex. 2004;72:394-9.

  19. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-90.

  20. Livingstone C, Livingstone LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulphate in women with mild preeclampsia: a randomized controlled trial. Obtest Gynecol. 2003;101(2):217-20.

  21. Congreso Nacional de Neonatología. Repercusión neonatal de la preeclampsia recurrente. Boletín Médico del hospital Infantil de México. 2006;63(1):53-7.

  22. Vázquez Niebla JC, Vázquez Cabrera J. Asociación entre la hipertensión arterial durante el embarazo, bajo peso al nacer y algunos resultados del embarazo y el parto. Rev Cubana Obstet Ginecol. 2003;29(1).

  23. Barreto S. Factores de riesgo y resultados perinatales en la Preeclampsia Severa. Un estudio caso control. Revista del Hospital Materno Infantil "Ramón Sardá". 2003;22(3).

  24. Uberti E, Vicosa H, Conter S, Schutt D, Rodrigues L, Costa P. Morbidade e mortalidade perinatal nos disturbios hipertensivos da gestacao. Rev Bras Ginecol Obstet. 1994;16:81-8.




2020     |     www.medigraphic.com